CytoDyn Inc. (CYDY)

CytoDyn Balance Sheet

Financials in millions USD. Fiscal year is June - May.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2.54	4.23	33.94	14.28	2.61
Cash & Cash Equivalents	2.54	4.23	33.94	14.28	2.61
Cash Growth	-39.94%	-87.53%	137.67%	446.59%	112.18%
Receivables	0	17.93	0	0	0.09
Inventory	0	17.93	93.48	19.15	-0.09
Other Current Assets	8.26	-11.65	2.16	3.4	2.76
Total Current Assets	10.81	28.44	129.58	36.83	5.37
Property, Plant & Equipment	0.4	0.61	0.85	0.23	0.03
Intangible Assets	0	0.13	1.65	13.46	15.48
Other Long-Term Assets	0.09	0	0	0	0
Total Long-Term Assets	0.49	0.74	2.5	13.69	15.5
Total Assets	11.29	29.19	132.08	50.51	20.87
Accounts Payable	62.73	67.97	65.9	29.48	16.24
Deferred Revenue	22.58	0	0	8.15	0
Current Debt	34.42	36.38	62.92	6.86	7.79
Other Current Liabilities	0.08	18.81	23.73	0.01	2.9
Total Current Liabilities	119.8	123.16	152.55	44.5	26.93
Long-Term Debt	1	0.42	0.55	8.49	0.45
Other Long-Term Liabilities	0	0	0	0	2.41
Total Long-Term Liabilities	1	0.42	0.55	8.49	2.86
Total Liabilities	120.79	123.58	153.1	52.99	29.79
Total Debt	35.41	36.8	63.47	15.35	8.24
Debt Growth	-3.76%	-42.03%	313.43%	86.31%	-
Common Stock	0.92	0.72	0.63	0.52	0.33
Retained Earnings	-841.69	-766.13	-511.29	-354.71	-229.36
Comprehensive Income	0	-0	-2.65	0	0
Shareholders' Equity	-109.5	-94.4	-21.02	-2.48	-8.91
Total Liabilities and Equity	11.29	29.19	132.08	50.51	20.87
Net Cash / Debt	-32.87	-32.57	-29.53	-1.07	-5.63
Net Cash Per Share	-0.04	-0.05	-0.05	-0.00	-0.02
Working Capital	-108.99	-94.72	-22.97	-7.67	-21.56
Book Value Per Share	-0.13	-0.14	-0.04	-0.01	-0.03

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.